Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| SPDR Gold SharesGOLD SHS(GLD) | 6,964 | 7,623 | +659 | $2.76M | $3.28M | 81.50% | +$520.0K |
| Berkshire Hathaway Inc DelCL B | 710 | 727 | +17 | $356.8K | $348.3K | 8.66% | -$8.4K |
| Kyverna Therapeutics, Inc.(KYTX) | 18,773 | 18,773 | 0 | $176.5K | $162.0K | 4.03% | -$14.5K |
| Lexeo Therapeutics, Inc.(LXEO) | 13,943 | 13,943 | 0 | $138.5K | $80.0K | 1.99% | -$58.4K |
| X4 Pharmaceuticals, Inc.(XFOR) | 15,557 | 15,557 | 0 | $62.2K | $64.2K | 1.60% | +$2.0K |
| Inhibikase Therapeutics, Inc.(IKT) | 28,453 | 28,453 | 0 | $58.3K | $47.8K | 1.19% | -$10.5K |
| ALX Oncology Holdings Inc.(ALXO) | 0 | 20,946 | +20,946 | $0 | $42.0K | 1.04% | +$42.0K |
| Compass Therapeutics, Inc.(CMPX) | 29,495 | 0 | -29,495 | $158.4K | $0 | — | -$158.4K |
| Context Therapeutics Inc.(CNTX) | 18,403 | 0 | -18,403 | $27.1K | $0 | — | -$27.1K |
| Mind Medicine Mindmed Inc | 15,688 | 0 | -15,688 | $210.1K | $0 | — | -$210.1K |
| SAB Biotherapeutics, Inc.(SABS) | 10,527 | 0 | -10,527 | $39.4K | $0 | — | -$39.4K |
| Spyre Therapeutics, Inc.(SYRE) | 8,919 | 0 | -8,919 | $292.2K | $0 | — | -$292.2K |